BioSpace News Archive

Drug Development

Retinal Tissue Restored in Patients with Dry AMD, Heralding Paradigm Shift

Retinal tissue has been regrown in three patients with age-related macular degeneration with geographic atrophy or dry (atrophic) AMD in a Phase I/IIa study conducted by Lineage Cell Therapeutics.

June 13, 2021
·
4 min read
·
Gail Dutton
Policy

Statement from the Chief Public Health Officer of Canada on June 13, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

June 13, 2021
·
6 min read
Drug Development

RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis

RAPT Therapeutics, Inc. announced that the Company plans to report top line data from its Phase 1b clinical trial of RPT193 in patients with moderate to severe atopic dermatitis in a premarket press release and webcast on Monday, June 14, 2021.

June 13, 2021
·
1 min read
Drug Development

Molecular Partners Announces First Patient Dosed in COVID-19 NIH-Sponsored ACTIV-3 Trial Evaluating Antiviral Candidate Ensovibep

Molecular Partners AG announced that the first patient has been dosed in a new Phase 3 sub-study evaluating ensovibep, as part of the National Institutes of Health’s Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership designed to speed development of treatments and vaccine candidates for COVID-19.

June 13, 2021
·
8 min read
Drug Development

Terns Pharmaceuticals to Host Conference Call to Discuss Top-line Results from Phase 2a LIFT Study of TERN-101 for Treatment of NASH

Terns Pharmaceuticals, Inc. announced that the Company will host a conference call and live webcast on Monday, June 14, 2021 at 8:30 a.m. ET to discuss new top-line data from the Phase 2a LIFT study evaluating TERN-101 in patients with NASH.

June 13, 2021
·
1 min read